Designing and Testing New Therapeutic Modalities for Treatment of Inflammatory Bowel Disease: Role of Experimental Animal Models

Publisher： Bentham Science Publishers

E-ISSN： 1875-6131|4|3|297-317

ISSN： 1568-0142

Source： Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.4, Iss.3, 2005-06, pp. : 297-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Rifaximin in Inflammatory Bowel Disease Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 3, 2016-02 ,pp. : 225-229

Bentham Science Publishers

Access to resources Recommend Favorite

New developments in the treatment of inflammatory bowel disease

By Keshavarzian Ali   Farhadi Ashkan   Mutlu Ece A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 365-385

Informa Healthcare

Access to resources Recommend Favorite

Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 285-300

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 111-123

Bentham Science Publishers

Access to resources Recommend Favorite

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease

By Mitsuyama Keiichi   Sata Michio  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite